Status:

COMPLETED

Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy

Lead Sponsor:

Integra LifeSciences Corporation

Conditions:

Fibroid

Myoma

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This study is planned as a prospective, randomised, parallel, controlled, multi-centre, open label, comparative evaluation of SprayShield™ Adhesion Barrier plus good surgical technique, versus good su...

Eligibility Criteria

Inclusion

  • Females, 18 years of age or older, of child-bearing potential.
  • Subject has at least one myoma \>= 3 cm.

Exclusion

  • Pregnant or lactating females.
  • Females undergoing prior open or closed myomectomy for treatment of myomas.
  • Evidence of current active endometriosis or infection
  • History of or active inflammatory bowel disease or pelvic inflammatory disease.
  • Presence of a frozen pelvis, or hydrosalpinges.

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2009

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT00891657

Start Date

November 1 2008

End Date

May 1 2009

Last Update

September 7 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pius Clinic

Oldenburg, Germany

Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy | DecenTrialz